X L Teng, J Zhang, X T Chang, S R Li, J Zhou, Y H Zhang, X H Bao, Y W Jiang, Y Wu
Objective: To summarize the clinical characteristics of myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) and compare the differences in efficacy of different disease-modifying drugs. Methods: An ambispective cohort study was conducted in 42 children diagnosed with MOGAD at Department of Pediatrics, Peking University First Hospital from January 2012 to March 2021 and conducted long-term follow-up to analyze clinical phenotypes and compare the efficacy of different disease-modifying drugs such as rituximab, mycophenolate mofetil and azathioprine...
December 2, 2021: Zhonghua Er Ke za Zhi. Chinese Journal of Pediatrics